Michael S. Conte, MD
- Interim Chief, Division of Cardiothoracic Surgery
- Professor & Chief, Division of Vascular and Endovascular Surgery
- Edwin J. Wylie, M.D. Chair in Vascular Surgery
- Co-Director, UCSF Heart and Vascular Center
- Co-Director, UCSF Center for Limb Preservation
- Director, Vascular Surgery Fellowship & Integrated Residency Programs
Contact Information
Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Education
-
1978-82, Boston University, B.S., Biomedical Engineering
- 1982-86, Albert Einstein College of Medicine, M.D., Medicine
Residencies
- 1986-88, New York Hospital, Cornell Medical Center, Junior Resident, General Surgery
- 1988-89, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
- 1991-92, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
- 1992-93, New York Hospital, Cornell Medical Center, Chief Resident, General Surgery
Fellowships
- 1989-91, Brigham and Women's Hospital/Harvard, Research Fellow, Vascular Surgery
- 1993-94, Harvard Medical School, Fellow, Vascular Surgery
- 1993-94, Brigham and Women's Hospital, Fellow, Vascular Surgery
Biography
Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.
Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).
Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.
In 2017, Dr. Conte was named to Castle Connolly's list of the "Bay Area Top Doctors 2017" for Vascular Surgery.
Awards & Honors
Award
Confired By
Date
Research Overview
Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.
Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.
Research & Funding
Data provided by UCSF Profiles, powered by CTSI
- UCSF Diabetic Foot Clinical Research UnitSponsor: NIH/NIDDKSponsor ID: U01DK119100Funding Period:Sep 2018-Jun 2022Principal Investigator
- Tissue Oxygen Monitoring in Peripheral Vascular DiseaseSponsor: NIH/NHLBISponsor ID: R44HL131366Funding Period:Apr 2016-Jul 2020Co-Principal Investigator
- Specialized lipid mediators and mechanisms of resolution in vascular injurySponsor: NIH/NHLBISponsor ID: R01HL119508Funding Period:Aug 2013-May 2017Principal Investigator
- IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014Sponsor: NIHSponsor ID: 268201400005C-0-0-1Funding Period:Nov 2013-Nov 2014Principal Investigator
- Survivin: a novel regulator of intimal hyperplasia and vein graft remodelingSponsor: NIH/NHLBISponsor ID: R01HL085157Funding Period:Aug 2007-Jun 2013Principal Investigator
- General Clinical Research CenterSponsor: NIHSponsor ID: M01RR002635Funding Period:Dec 1984-Mar 2010Co-Investigator
- GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFTSponsor: NIH/NHLBISponsor ID: K08HL004189Funding Period:Sep 1999-Aug 2004Principal Investigator
Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
- Study ID: NCT06104969Start Date: Jun 2023Estimated Completion Date: Jun 2028Condition(s): Diabetes, Diabetic Ulcer
- Study ID: NCT05313165Start Date: Dec 2022Estimated Completion Date: May 2027Condition(s): Chronic Limb-Threatening Ischemia, Critical Limb Ischemia, Peripheral Artery Disease, Vascular Disease
- Study ID: NCT05092620Start Date: May 2021Estimated Completion Date: Dec 2024Condition(s): Diabetic Foot Ulcer
- Study ID: NCT04591691Start Date: Oct 2020Estimated Completion Date: Jan 2023Condition(s): Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
- Study ID: NCT04514861Start Date: Aug 2020Estimated Completion Date: Dec 2021Condition(s): Peripheral Arterial Disease
- Study ID: NCT04558775Start Date: Jun 2020Estimated Completion Date: Sep 2022Condition(s): Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
- Study ID: NCT04267640Start Date: Jan 2020Estimated Completion Date: Jan 2023Condition(s): Peripheral Arterial Disease, Chronic Limb Threatening Ischemia, Ischemic Ulcer of Foot
- Study ID: NCT03970538Start Date: Dec 2019Estimated Completion Date: Dec 2023Condition(s): Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia, Arterial Occlusive Diseases, Arterial Occlusion, Peripheral Artery Occlusion, Vascular Disease, Peripheral Ischemia
- Study ID: NCT03551496Start Date: Aug 2018Estimated Completion Date: Mar 2027Condition(s): Critical Limb Ischemia
- Study ID: NCT03590769Start Date: Jun 2017Estimated Completion Date: Jun 2021Condition(s): Peripheral Arterial Disease, Claudication, Intermittent, Claudication, SFA - Superficial Femoral Artery Stenosis, Vascular Calcification
- Study ID: NCT02887859Start Date: Dec 2016Estimated Completion Date: Dec 2023Condition(s): Peripheral Arterial Disease
- Study ID: NCT02805023Start Date: Jun 2016Estimated Completion Date: Dec 2023Condition(s): Critical Limb Ischemia, Peripheral Arterial Disease, Vascular Disease
- Study ID: NCT02719665Start Date: Mar 2016Estimated Completion Date: Dec 2019Condition(s): Peripheral Arterial Disease, Claudication, Claudication, Intermittent, Vascular Occlusion, Vascular Calcification, Vascular Disease, Osteoarthritis
- Study ID: NCT02180373Start Date: Dec 2012Estimated Completion Date: Dec 2017Condition(s): Peripheral Arterial Disease
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 348
Data provided by UCSF Profiles, powered by CTSI
- Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong M, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ. Surgery or Endovascular Therapy for Patients with Chronic Limb-threatening Ischemia Requiring Infrapopliteal Interventions. J Vasc Surg. 2024 Jun 20. View in PubMed
- Bose S, Dun C, Solomon AJ, Black JH, Conte MS, Kalbaugh CA, Woo K, Makary MA, Hicks CW. Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes. Eur J Vasc Endovasc Surg. 2024 Jun 19. View in PubMed
- Bose S, McDermott KM, Dun C, Mao J, Solomon AJ, Black JH, Columbo JA, Conte MS, Deery SE, Goodney PP, Kalathiya R, Kalbaugh CA, Siracuse JJ, Woo K, Makary MA, Hicks CW. Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry Patients. Ann Surg. 2024 Jun 06. View in PubMed
- Zarrintan S, Rahgozar S, Ross EG, Farber A, Menard MT, Conte MS, Malas MB. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice. J Vasc Surg. 2024 May 06. View in PubMed
- Streifel AC, Rivera Sarti JE, Sikka MK, Conte M, Winders B, Varley CD. Fixing a Hole: a retrospective cohort study evaluating HAV, HBV, tetanus screening, and vaccination during hospitalization in persons who use substances. Ther Adv Infect Dis. 2024 Jan-Dec; 11:20499361241245822. View in PubMed
- View All Publications
In the News
- Vascular Specialist - June 29, 2023"UC San Francisco Medical Center (UCSF) is among the first four hospitals in the U.S. to be verified as part of the American College of Surgeons' (ACS) Vascular Verification Program (Vascular-VP), a quality program recently launched in partnership with the Society for Vascular Surgery (SVS)." (Vascular Online Specialist 2023)
- UCSF Division of Vascular & Endovascular Surgery - - November 09, 2022BEST-CLI is an international research study aimed at figuring out the best treatment for people with peripheral arterial disease (PAD) - also known as poor blood flow, and associated with Critical Limb Ischemia (CLI). It is Federally funded by the National Heart, Lung and Blood Institute at the National Institutes of Health. As of November 2022, BEST-CLI enrollment ended in October of 2019, and completed a minimum of 24 months' follow-up for all patients in October of 2021. The primary [...]
- Division of Vascular & Endovascular Surgery - - December 12, 2019Michael Conte, Professor and Chief of the UCSF Division of Vascular & Endovascular Surgery, has recently received the Distinguished Achievement Award from the American Heart Association Council on Peripheral Vascular Disease (PVD). PVD Council Chair Naomi Hamburg, MD presented the award to Dr. Conte at the AHA Scientific Sessions meeting held in Philadelphia, PA on November 16, 2019. The PVD Council has released the following statement regarding Dr. Conte's selection for the award: Dr. [...]
- Division of Vascular and Endovascular Surgery - - November 19, 2019Michael Conte, MD, Professor and Chief of the UCSF Division of Vascular & Endovascular Surgery, has recently been selected to serve as President of the Western Vascular Society for the 2020-2021 annual cycle. The Western Vascular Society has released the following statement regarding the appointment: Nominations Committee Names Dr. Michael Conte as President Elect of Western Vascular Society At the 34th Western Vascular Society Annual Business Meeting at the Fairmont Kei Lani, Maui, [...]
- UCSF Division of Vascular & Endovascular Surgery - - June 12, 2019The Global Vascular Guidelines for the Treatment of Chronic Limb-Threatening Ischemia (CLTI), an initiative to standardize and improve the quality of care of patients with CLTI worldwide, has been published in the Journal of Vascular Surgery (JVS), as a supplement to the June 2019 edition. The global effort was spearheaded by a trio of internationally renowned vascular surgeons who served as co-editors of the publication: Michael S. Conte, M.D., Professor and Chief of the Division of [...]
- UCSF Center for Limb Preservation - - October 26, 2018Michael S. Conte, MD, chief of the Division of Vascular and Endovascular Surgery at UCSF, and one of nation's leading vascular surgeons, was awarded a 4-year, $1.7M U01 grant by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), a unit of the NIH, to fund one of 6 national centers in the Diabetic Foot Consortium. Conte and podiatrist Alexander Reyzelman, DPM, a co-investigator on the grant, are co-Directors of the UCSF Center for Limb Preservation. The NIDDK research [...]
- UCSF Vascular & Endovascular Surgery - - February 08, 2018The Division of Vascular and Endovascular Surgery in the Department of Surgery at University of California, San Francisco will host the 2018 UCSF Vascular Symposium on April 19-21 at the Parc 55 San Francisco. The symposium includes a distinguished faculty drawn from UCSF and and other leading institutions. The landscape of vascular disease management continues to evolve with advancing technologies, data from clinical trials, and registries, all within the shifting paradigms of affordable [...]
- UCSF Division of Vascular & Endovascular Surgery - - May 03, 2017Michael S. Conte, M.D., Professor and Chief of the Division of Vascular & Endovascular Surgery and Director of the Conte Lab, has been awarded two grants to develop a prototype medical device that will deliver bioactive lipid mediators to prevent "restenosis", the recurrent narrowing of blood vessels following interventions such as angioplasty, stenting, and bypass surgery. The bioactive compounds are being developed in the Conte Lab. The first grant, a $200.000 Technology Development [...]
- UCSF Center for Limb Preservation & Wound Care - - June 22, 2016The UCSF Division of Vascular & Endovascular Surgery recently launched a new website for its Center for Limb Preservation & Wound Care. The program, led by vascular surgeon Michael S. Conte, M.D. and podiatric surgeon Alexander M. Reyzelman, D.P.M., is the first of its kind in the Bay Area — pooling the expertise of vascular surgeons, podiatrists, reconstructive microsurgeons, nurse practitioners and other specialists to provide integrated, multidisciplinary care for patients at high [...]
- UCSF Vascular & Endovascular Surgery - August 01, 2015UCSF Magazine reports on the work of researchers using potent compounds, produced naturally from fish oil, to block the inflammation that can reblock arteries opened during stent procedures. Michael S. Conte, M.D. Chief of the Division of Vascular & Endovascular Surgery and Director of the Conte Lab, and other researcher are collaborating in this endeavor: Doctors implant more than a half million stents annually to prop open patients' blocked arteries and restore their blood flow. But [...]
- UCSF Vascular & Endovascular Surgery - April 14, 2015The NHLBI Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program has awarded Michael S. Conte, M.D., Professor & Chief of the Division of Vascular & Endovascular Surgery, a translational research grant to study the problem of vascular injury and develop prototype medical drugs and devices that effectively prevent restenosis, reduce vascular scarring, and improve vascular surgical outcomes. The grant is a collaboration between the Conte Lab and Tejal Desai, Ph.D., [...]
- UCSF Center for Surgery in Older Adults - April 06, 2015UCSF News reports that U.S. only a small number of nursing home residents are alive and ambulatory one year after undergoing lower extremity revascularization procedures with those still alive gaining little, if any, function: Only a few U.S. nursing home residents who undergo lower extremity revascularization procedures are alive and ambulatory a year after surgery, according to UCSF researchers, and most patients still alive gained little, if any, function. The study appears in the April [...]
- UCSF Vascular & Endovascular Surgery - November 27, 2014Every year, more than a half-million Americans undergo procedures to have a narrowed coronary artery propped open with a small metal mesh tube, or stent. The procedure is common for certain patients who've experienced a heart attack or other arterial blockages, and it helps to restore blood flow. But in about one in four cases (one in three if it's your leg artery), the vasculature tissue starts renarrowing again after the procedure, effectively regrowing the blockage. The problem of excessive [...]
- UCSF Vascular & Endovascular Surgery - February 07, 2014Advances in the treatment of complex aortic aneurysms — especially novel endovascular devices and hybrid procedures — make it possible to choose the right procedure for the right patient at the right time to minimize risk and maximize long-term benefit, says Michael Conte, M.D., chief of the Division of Vascular and Endovascular Surgery at UCSF Medical Center. "We still perform a significant volume of open repair for complex aneurysms," Conte says. "But we're also one of only two or three [...]
- UCSF Vascular & Endovascular Surgery - December 06, 2011The UCSF Division of Vascular & Endovascular Surgery announces the opening of the UCSF Center for Limb Preservation & Wound Care. Led by vascular surgeon Michael S. Conte, M.D. (pictured left), and podiatric surgeon Alexander M. Reyzelman, D.P.M. (pictured right), the Center, the first of its kind in the Bay Area, pools the expertise of vascular surgeons, podiatrists and other specialists to provide integrated, multidisciplinary, care for patients at high risk of foot and leg [...]
- UCSF Vascular & Endovascular Surgery - June 20, 2011Bypass surgery to repair blocked arteries in the legs leads to more durable and long-lasting results in approximately twenty-percent of patients with two copies of a specific gene variation, one inherited from each parent. The study, co-funded by Vascular Cures and the NIH, was led by Michael S. Conte, M.D., Chief of the Division of Vascular & Endovascular Surgery, and co-director of the Heart and Vascular Center at UCSF and Alexander Clowes, M.D., Professor of Surgery at the University [...]
- UCSF Vascular & Endovascular Surgery - February 17, 2009Despite substantial research showing that Peripheral artery disease (PAD) puts people at increased risk for heart attack, stroke, amputation and other vascular-related coniditions, PAD remains significantly underdiaganosed and undertreated. "These are very vulnerable patients," says Michael S. Conte, MD,, chief of Vascular and Endovascular Surgery at UCSF Medical Center and one of the country's leading PAD experts. "Most are over 70. Many are diabetics or smokers or both, and have [...]
Patient Stories
- John Maduell
Conceptual Artist Retains Limb Against Long Odds
In his 33-year career as a conceptual artist at Lawrence Livermore National Laboratory, John Maduell illustrated futuristic technologies few others could imagine. But he never envisioned the toll diabetes and vascular disease would take on his body—or that one day he might lose his legs because of these problems. Maduell's troubles started two years ago when he developed a diabetic ulcer on his left foot. "Before I knew it, I was in the hospital, with three toes amputated," he says. Still, the wound didn't heal, and Maduell, who now lives and paints in Modesto, was told removing the[...] - Bicknell Ramsay
Multidisciplinary Cardiovascular Treatment Saves Limb
Bicknell Ramsay — a 74-year-old retired engineer who lives a fully active life — was concerned that a wound on his foot would not heal. Having volunteered for a clinical study on peripheral artery disease (PAD), he described the wound to the principal investigator, UCSF nurse practitioner Roberta Oka, R.N., DNSc. She referred Ramsay to Michael S. Conte, M.D., (pictured at right on left), Chief of Vascular and Endovascular Surgery at UCSF Medical Center. By then, the wound exceeded two centimeters and was enlarging. After an ankle-brachial index test found only 30 percent of normal[...]